Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
vivek subbiah
Sep 23, 2023, 20:03 |
Blog
Vivek Subbiah: Super honored to deliver the lecture on “Precision Oncology Paradigm: Unlocking Phenotypic Plasticity, Resistance and Treatment” at the Brown University 2023 Legoretta Cancer Center Symposium.
Sep 21, 2023, 19:49 |
Blog
Vivek Subbiah: Super thrilled to discuss how to overcome tumor plasticity in the clinic and how can we design clinical trials with customized combinations to overcome this.
Sep 18, 2023, 17:16 |
Blog
Vivek Subbiah: Exhilarating discussions with my dear friend and amazing colleague Naveen Pemmaraju.
Vivek Subbiah, Executive Director at MDACC Cancer Network, shared on X/Twitter: “Exhilarating discussions with my…
Sep 16, 2023, 19:08 |
Insight
Vivek Subbiah: Super thrilled to deliver the keynote lecture on “Precision Oncology: Future is now” at the Binaytara Foundation.
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, recently shared…
Sep 13, 2023, 14:04 |
Insight
Vivek Subbiah: Super thrilled to share our paper - Variant of allele frequency: a decision-making tool in precision oncology?
Vivek Subbiah, Chief, Early-Phase Drug Development, Sarah Cannon Research Institute, made the following post on…
Sep 7, 2023, 19:58 |
Insight
Vivek Subbiah: Super delighted to Join Dr. Stephen V Liu to share my thoughts...
Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, on…
Sep 7, 2023, 19:57 |
Positive
Vivek Subbiah: Keep taking steps forward, even if it feels impossible to turn back.
Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, on…
Sep 5, 2023, 17:18 |
Insight
Vivek Subbiah: Give the right drug, to the right patient, at the right time in every country, to think globally and act locally.
Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, on LinkedIn:…
Aug 31, 2023, 19:03 |
Insight
Vivek Subbiah: The evidence for different approaches to colorectal cancer screening is reviewed and a framework for evaluation of screening programs going forward is proposed.
Aug 30, 2023, 17:46 |
Insight
Vivek Subbiah: Adding chemotherapy to cemiplimab at progression might provide a new second-line treatment for patients with advanced non-small-cell lung cancer.
In a post by Vivek Subbiah, the Chief Early-Phase Drug Development at Sarah Cannon Research…
23
24
25
26
27
All:
341
Posts:
241 - 250
Top 100 Xfluencers in Pediatric Hematology/Oncology: Key Opinion Leaders to follow on X (Twitter) in 2024
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube